| Albendazole |
№ ІІ- 12589/22.03.2011 |
ZENTEL, Tablet, 400, mg, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
Glaxo Wellcome Production, France Glaxo Wellcome GmbH & Co, Germany |
3.07 |
0.61 |
3.68 |
7% |
0.21 |
3.28 |
0.66 |
3.94 |
20% |
0.61 |
3.89 |
0.78 |
4.67 |
|
КЦ-2286/01.06.2011 |
15.06.2011 |
15.06.2011 |
Неактивен |
2784 |
| Cefazolin |
№ II - 9608/18.05.2010 |
ZEPILEN, Powder for solution for injection/infusion, 1000, mg, Pack: 10 |
Medochemie Ltd., Кипър |
Medochemie Ltd. - Lomassol, Кипър |
17.6 |
3.52 |
21.12 |
6% |
1.06 |
18.66 |
3.73 |
22.39 |
18% |
3.17 |
21.83 |
4.37 |
26.2 |
|
КЦ-2979/14.10.2011 |
02.11.2011 |
02.11.2011 |
Активен |
1129 |
| Simvastatin |
II-12094/04.01.2006 г. |
ZEPLAN 10 MG, Film coated tablet, 10, mg, Pack: 28 |
Gedeon Richter Romania Ltd., Румъния |
Gedeon Richter Romania Ltd.,Romania |
2.52 |
0.5 |
3.02 |
7% |
0.18 |
2.7 |
0.54 |
3.24 |
20% |
0.5 |
3.2 |
0.64 |
3.84 |
|
НСР-8519/16.03.2016; НСР-10695/21.10.2016 |
31.03.2016 |
02.12.2016 |
Заличен |
845 |
| Simvastatin |
II-12094/04.01.2006 г. |
ZEPLAN 10 MG, Film coated tablet, 10, mg, Pack: 28 |
Gedeon Richter Romania Ltd., Румъния |
Gedeon Richter Romania Ltd.,Romania |
2.52 |
0.5 |
3.02 |
7% |
0.18 |
2.7 |
0.54 |
3.24 |
20% |
0.5 |
3.2 |
0.64 |
3.84 |
|
НСР-8519/16.03.2016 |
31.03.2016 |
31.03.2016 |
Неактивен |
845 |
| Simvastatin |
II-12094/04.01.2006 г. |
ZEPLAN 10 MG, Film coated tablet, 10, mg, Pack: 28 |
Gedeon Richter Romania Ltd., Румъния |
Gedeon Richter Romania Ltd.,Romania |
2.6 |
0.52 |
3.12 |
7% |
0.18 |
2.78 |
0.56 |
3.34 |
20% |
0.52 |
3.3 |
0.66 |
3.96 |
|
КЦ-1247/22.12.2009 |
17.01.2010 |
17.01.2010 |
Неактивен |
845 |
| Simvastatin |
II-12095/04.01.2006 г. |
ZEPLAN 20 MG, Film coated tablet, 20, mg, Pack: 28 |
Gedeon Richter Romania Ltd., Румъния |
Gedeon Richter Romania Ltd.,Romania |
4.75 |
0.95 |
5.7 |
7% |
0.33 |
5.08 |
1.02 |
6.1 |
20% |
0.95 |
6.03 |
1.21 |
7.24 |
|
НСР-8518/16.03.2016; НСР-10696/21.10.2016 |
31.03.2016 |
02.12.2016 |
Заличен |
846 |
| Simvastatin |
II-12095/04.01.2006 г. |
ZEPLAN 20 MG, Film coated tablet, 20, mg, Pack: 28 |
Gedeon Richter Romania Ltd., Румъния |
Gedeon Richter Romania Ltd.,Romania |
4.75 |
0.95 |
5.7 |
7% |
0.33 |
5.08 |
1.02 |
6.1 |
20% |
0.95 |
6.03 |
1.21 |
7.24 |
|
НСР-8518/16.03.2016 |
31.03.2016 |
31.03.2016 |
Неактивен |
846 |
| Simvastatin |
II-12095/04.01.2006 г. |
ZEPLAN 20 MG, Film coated tablet, 20, mg, Pack: 28 |
Gedeon Richter Romania Ltd., Румъния |
Gedeon Richter Romania Ltd.,Romania |
4.93 |
0.99 |
5.92 |
7% |
0.35 |
5.28 |
1.06 |
6.34 |
20% |
0.99 |
6.27 |
1.25 |
7.52 |
|
КЦ-1247/22.12.2009 |
17.01.2010 |
17.01.2010 |
Неактивен |
846 |
| Letrozole |
ІІ-10085/ 24.06.2010 |
ZEQUIPRA, Film coated tablet, 2.5, mg, Pack: 30 |
Неола Фарма ЕООД, България |
West Pharma Португалия |
32.06 |
6.41 |
38.47 |
4% |
1.28 |
33.34 |
6.67 |
40.01 |
16% |
5.13 |
38.47 |
7.69 |
46.16 |
Промяна в обстоятелствата НСР-6744/16.07.2015 |
НСР-2859/21.02.2014 |
11.03.2014 |
11.03.2014 |
Активен |
2536 |
| Letrozole |
ІІ-10085/ 24.06.2010 |
ZEQUIPRA, Film coated tablet, 2.5, mg, Pack: 30 |
Ромастру Трейдинг ЕООД, България |
West Pharma Португалия |
39.98 |
8 |
47.98 |
4% |
1.6 |
41.58 |
8.32 |
49.9 |
16% |
6.4 |
47.98 |
9.6 |
57.58 |
|
НСР-1102/04.09.2013 |
19.09.2013 |
19.09.2013 |
Неактивен |
2536 |
| Letrozole |
ІІ-10085/ 24.06.2010 |
ZEQUIPRA, Film coated tablet, 2.5, mg, Pack: 30 |
Ромастру Трейдинг ЕООД, България |
West Pharma Португалия |
61.96 |
12.39 |
74.35 |
4% |
2.48 |
64.44 |
12.89 |
77.33 |
16% |
9.91 |
74.35 |
14.87 |
89.22 |
|
КЦРР-445/19.04.2012 |
06.06.2012 |
06.06.2012 |
Неактивен |
2536 |
| Letrozole |
№ ІІ-10085/24.06.2010 |
ZEQUIPRA, Film coated tablet, 2.5, mg, Pack: 30 |
Ромастру Трейдинг ЕООД, България |
West Pharma Португалия |
162.54 |
32.51 |
195.05 |
6% |
9.75 |
172.29 |
34.46 |
206.75 |
18% |
29.26 |
201.55 |
40.31 |
241.86 |
|
КЦ-1961/25.01.2011 |
09.02.2011 |
09.02.2011 |
Неактивен |
2536 |
| Stavudine |
EU/1/96/009/008 |
ZERIT, Capsule, hard, 40, mg, Pack: 56 |
Bristol-Myers Squibb Pharma EEIG, Обединено Кралство |
Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, 19250 Meymac, France |
217.02 |
43.4 |
260.42 |
4% |
8.68 |
225.7 |
45.14 |
270.84 |
16% |
25 |
250.7 |
50.14 |
300.84 |
цената е заличена с решение КЦРР-1533/25.10.2012 |
КЦРР-687/30.05.2012 |
20.06.2012 |
20.06.2012 |
Заличен |
1226 |
| Stavudine |
EU/1/96/009/006 |
ZERIT, Capsule, hard, 30, mg, Pack: 56 |
Bristol-Myers Squibb Pharma EEIG, Обединено Кралство |
Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, 19250 Meymac, France |
210.02 |
42 |
252.02 |
4% |
8.4 |
218.42 |
43.68 |
262.1 |
16% |
25 |
243.42 |
48.68 |
292.1 |
цената е заличена с решение КЦРР-1533/25.10.2012 |
КЦРР-687/30.05.2012 |
20.06.2012 |
20.06.2012 |
Заличен |
1225 |
| Stavudine |
EU/1/96/009/008 |
ZERIT, Capsule, hard, 40, mg, Pack: 56 |
Bristol-Myers Squibb Pharma EEIG, Обединено Кралство |
Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, 19250 Meymac, France |
240.88 |
48.18 |
289.06 |
6% |
14.45 |
255.33 |
51.07 |
306.4 |
18% |
30 |
285.33 |
57.07 |
342.4 |
|
КЦ-497/04.02.2009 |
10.03.2009 |
10.03.2009 |
Неактивен |
1226 |
| Stavudine |
EU/1/96/009/006 |
ZERIT, Capsule, hard, 30, mg, Pack: 56 |
Bristol-Myers Squibb Pharma EEIG, Обединено Кралство |
Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, 19250 Meymac, France |
233.12 |
46.62 |
279.74 |
6% |
13.99 |
247.11 |
49.42 |
296.53 |
18% |
30 |
277.11 |
55.42 |
332.53 |
|
КЦ-497/04.02.2009 |
10.03.2009 |
10.03.2009 |
Неактивен |
1225 |
| Ibritumomab tiuxetan |
EU/1/03/264/001 |
Zevalin, -, 3.2, mg, Pack: 1 |
Spectrum Pharmaceuticals B.V., Нидерландия |
CIS bio international RN 306-Saclay B.P.32 91192 GIF Sur Yvette Cedex, France |
17651.23 |
3530.25 |
21181.48 |
4% |
10 |
17661.23 |
3532.25 |
21193.48 |
16% |
25 |
17686.23 |
3537.25 |
21223.48 |
|
КЦРР-2944/20.03.2013 |
19.04.2013 |
19.04.2013 |
Неактивен |
2931 |
| Ibritumomab tiuxetan |
EU/1/03/264/001 |
Zevalin, -, 3.2, mg, Pack: 1 |
Bayer Schering Pharma AG,, Германия |
Bayer Schering Pharma AG, Germany |
19429.72 |
3885.94 |
23315.66 |
4% |
10 |
19439.72 |
3887.94 |
23327.66 |
16% |
25 |
19464.72 |
3892.94 |
23357.66 |
|
КЦ-353/19.12.2008 |
05.01.2009 |
05.01.2009 |
Неактивен |
2931 |
| Ibritumomab tiuxetan |
EU/1/03/264/001 |
ZEVALIN, Kit for radiopharmaceutical preparation, 1,6 mg/ml - 2 ml, -, Pack: 1 kit containing: 1 vial of ibritumomab tiuxetan, 1 vial of sodium acetate solution, 1 vial of formulation buffer and 1 empty reaction vial |
Spectrum Pharmaceuticals B.V., Нидерландия |
CIS bio international RN 306-Saclay B.P.32 91192 GIF Sur Yvette Cedex, France |
16300.36 |
3260.07 |
19560.43 |
4% |
10 |
16310.36 |
3262.07 |
19572.43 |
16% |
25 |
16335.36 |
3267.07 |
19602.43 |
корекц.НСР-3921/20.06.2014 |
НСР-3669/06.06.2014; НСР-10119/25.08.2016 |
02.10.2016 |
02.10.2016 |
Активен |
2931 |
| Ibritumomab tiuxetan |
EU/1/03/264/001 |
ZEVALIN, Kit for radiopharmaceutical preparation, 1,6 mg/ml - 2 ml, -, Pack: 1 kit containing: 1 vial of ibritumomab tiuxetan, 1 vial of sodium acetate solution, 1 vial of formulation buffer and 1 empty reaction vial |
Spectrum Pharmaceuticals B.V., Нидерландия |
CIS bio international RN 306-Saclay B.P.32 91192 GIF Sur Yvette Cedex, France |
17335.71 |
3467.14 |
20802.85 |
4% |
10 |
17345.71 |
3469.14 |
20814.85 |
16% |
25 |
17370.71 |
3474.14 |
20844.85 |
корекц.НСР-3921/20.06.2014 |
НСР-3669/06.06.2014 |
04.07.2014 |
04.07.2014 |
Неактивен |
2931 |
| Ibritumomab tiuxetan |
EU/1/03/264/001 |
ZEVALIN, Kit for radiopharmaceutical preparation, 1,6 mg/ml - 2 ml, -, Pack: 1 kit containing: 1 vial of ibritumomab tiuxetan, 1 vial of sodium acetate solution, 1 vial of formulation buffer and 1 empty reaction vial |
Spectrum Pharmaceuticals B.V., Нидерландия |
CIS bio international RN 306-Saclay B.P.32 91192 GIF Sur Yvette Cedex, France |
17335.71 |
3467.14 |
20802.85 |
4% |
10 |
17345.71 |
3469.14 |
20814.85 |
16% |
25 |
17370.71 |
3474.14 |
20844.85 |
корекц.НСР-3921/20.06.2014 |
НСР-3669/06.06.2014 |
04.07.2014 |
04.07.2014 |
Неактивен |
2931 |
| Solifenacin |
20110053 |
ZEVESIN, Film coated tablet, 5, mg, Pack: 30 |
Zentiva k.s., Чешка република |
Zentiva k.s. - Чешка република |
27.11 |
5.42 |
32.53 |
6% |
1.63 |
28.74 |
5.75 |
34.49 |
18% |
4.88 |
33.62 |
6.72 |
40.34 |
|
НСР-2534/24.01.2014 |
19.02.2014 |
19.02.2014 |
Активен |
274 |
| Solifenacin |
№ ІІ - 11791/19.01.2011 |
ZEVESIN, Film coated tablet, 5, mg, Pack: 30 |
Zentiva k.s., Чешка република |
Zentiva k.s. - Чешка република |
28.75 |
5.75 |
34.5 |
6% |
1.73 |
30.48 |
6.1 |
36.58 |
18% |
5.18 |
35.66 |
7.13 |
42.79 |
|
КЦРР-2222/06.02.2013 |
03.04.2013 |
03.04.2013 |
Неактивен |
274 |
| Solifenacin |
№ ІІ - 11791/19.01.2011 |
ZEVESIN, Film coated tablet, 5, mg, Pack: 30 |
Zentiva k.s., Чешка република |
Zentiva k.s. U Kabelovny 130, 102 37 Prague 10, Чешка Република,Zentiva a.s.Словашка република |
31.29 |
6.26 |
37.55 |
4% |
1.25 |
32.54 |
6.51 |
39.05 |
16% |
5.01 |
37.55 |
7.51 |
45.06 |
|
КЦ-2149/20.04.2011 |
05.05.2011 |
05.05.2011 |
Неактивен |
274 |
| Abacavir |
EU/1/99/112/001-002 |
ZIAGEN, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Operations UK Ltd ,Великобритания GlaxoSmithKline Pharmaceuticals S.A. Полша |
347.79 |
69.56 |
417.35 |
4% |
10 |
357.79 |
71.56 |
429.35 |
16% |
25 |
382.79 |
76.56 |
459.35 |
Цената е заличена с решение НСР-2721/06.02.2014 |
КЦ-1824/11.10.2010 |
16.11.2010 |
16.11.2010 |
Заличен |
971 |